过敏与脑肿瘤风险的关联:来自40项观察性研究的证据
该Meta分析纳入40项观察性研究(31项病例对照研究、9项队列研究),采用随机效应模型合并数据,结果显示过敏史与脑肿瘤风险降低相关(OR 0.78,95% CI 0.71-0.86),胶质瘤关联尤为明显。作者认为过敏可视为脑肿瘤的保护因素,尤其对胶质瘤,但需进一步前瞻性队列研究提供更高级别证据。
要点
- 过敏史与脑肿瘤风险降低相关(OR 0.78,95% CI 0.71-0.86)
- 至少2种过敏性疾病者脑肿瘤风险低于仅1种者(OR 0.65 vs 0.78)
- 胶质瘤风险与哮喘(OR 0.82)及湿疹(OR 0.84)呈负相关
核心结论
- 过敏应被视为脑肿瘤的保护因素,尤其对胶质瘤;需要进一步前瞻性队列研究提供更高级别的证据。
研究设计与样本
- Meta分析,共纳入40篇文章,包括31项病例对照研究和9项队列研究;采用随机效应模型合并数据。
主要发现
- 过敏史与脑肿瘤风险降低相关(OR 0.78,95% CI 0.71-0.86)。
- 与仅有1种过敏性疾病者(OR 0.78,95% CI 0.71-0.85)相比,至少有2种过敏性疾病者(OR 0.65,95% CI 0.58-0.73)的脑肿瘤风险可能更低。
- 成人(OR 0.75,95% CI 0.69-0.81)与儿童/青少年(OR 0.78,95% CI 0.62-0.97)均发现脑肿瘤风险降低。
- 过敏史与胶质瘤风险降低相关(OR 0.71,95% CI 0.61-0.81);胶质瘤风险与哮喘(OR 0.82,95% CI 0.74-0.91)和湿疹(OR 0.84,95% CI 0.72-0.98)呈负相关。
- 过敏与脑膜瘤风险降低存在趋势(OR 0.89,95% CI 0.74-1.07)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The potential association between the medical history of allergic conditions and brain tumors have been investigated. However, the agreement has not been reached. The aim of this meta-analysis was to explore the possible association between allergic disease and brain tumor risk. METHODS: A comprehensive search was conducted and eligible studies were identified. Random-effects model was applied to meta-analyze the data. RESULTS: In accordance with the retrieval strategy, 40 articles with 31 case-control studies and 9 cohort studies were enrolled in the present meta-analysis. The results suggested that history of allergy was associated with a decreased risk of brain tumor (OR 0.78, 95% CI 0.71-0.86). Compared to individuals with 1 allergic condition (OR 0.78, 95% CI 0.71-0.85), those with at least 2 allergic conditions (OR 0.65, 95% CI 0.58-0.73) may have a potentially lower brain tumor risk. Moreover, decreased brain tumor risk was found in both adults (OR 0.75, 95% CI 0.69-0.81) and children/adolescents (OR 0.78, 95% CI 0.62-0.97). Allergy history is associated with a decreased risk of glioma (OR 0.71. 95% CI 0.61-0.81). Besides, glioma risk is negatively associated with asthma (OR 0.82, 95% CI 0.74-0.91) and eczema (OR 0.84, 95% CI 0.72-0.98). There is a tendency that allergy is associated with decreased risk of meningioma (OR 0.89, 95% CI 0.74-1.07). CONCLUSIONS: Allergy should be considered as a protective factor for brain tumors, especially glioma. Further prospective cohort studies are needed to provide a higher level of evidence.
引用
- Pan Z, Zhang S, Cen S, et al. The association between allergy and risk of brain tumors: Evidence from 40 observational studies. Acta Neurochir (Wien). 2025. PMID: 40259050. doi:10.1007/s00701-025-06499-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。